1. Case report {#sec1}
==============

A fifty-six-year old female presented with a recent diminution of vision in the right eye of 3-months duration. The clinical evaluation revealed normal anterior segment, intact ocular motility and the visual acuity was counting fingers 27.5 inches. The fundus examination revealed a large round elevated submacular lesion with well-defined borders ([Fig. 1](#fig1){ref-type="fig"}). The Optical coherence tomography (OCT) revealed a well-defined large subfoveal lesion elevating the overlying retina ([Fig. 2](#fig2){ref-type="fig"}). The fluorescein angiography showed a hyperfluorescent lesion with a mild late leakage ([Fig. 3](#fig3){ref-type="fig"}). The examination of the left eye was unremarkable.Fig. 1Fundus photography showing yellow submacular lesion. (For interpretation of the references to colour in this figure legend, the reader is referred to the Web version of this article.)Fig. 1Fig. 2Optical Coherence Tomography (OCT) showing submacular lesion elevating the overlying reina.Fig. 2Fig. 3Fluorescein angiography demonstrated hyperfluorescent lesion with a mild late leakage.Fig. 3

An excisional biopsy was planned via a 23 gauge pars plana vitrectomy. Intraoperatively, a yellow round lesion was identified. It was well-defined with no firm adhesions to the optic nerve or the surrounding structures. It was possible to deliver the mass as one unit by enlarging the sclerotomy incision. It was a cystic soft yellowish-brown compressible lesion measuring 1 × 0.5 centimeters. The postoperative course was uneventful and the visual acuity of the patient improved to 0.1.

Histopathological examination demonstrated an angiomatous lesion formed of small vascular spaces lined by flat endothelial cells together with vacuolated stromal cells, however, there was no evidence of atypia, necrosis, specific infection or malignancy in all the examined sections ([Fig. 4](#fig4){ref-type="fig"}). A diagnosis of submacular sclerosing capillary hemangioblastoma was confirmed. The patient was referred to the medical oncology department for further systematic evaluation to exclude von-Hippel Lindau syndrome after pathology indicated the lesion to be a retinal capillary hemangioblastoma. Neuroimaging, urine analysis, renal ultrasonography were done and all results were normal.Fig. 4Histopathologic examination showing small vascular spaces lined with flat endothelial cells.Fig. 4

2. Discussion {#sec2}
=============

The sclerosing capillary angioma was first reported as a rare benign tumor arising from the lung, originating from pulmonary epithelium, hence the name 'Pneumocytoma' but it was a hemangioma rather than a hemangioblastoma.[@bib3] The retinal capillary hemangioblastoma is a rare tumor that may occur as an isolated lesion, but more commonly associated with von Hippel-Lindau syndrome.[@bib1]^,^[@bib2] The tumor can be located anywhere in the fundus, with juxtapapilary site is common with early involvement of the macula with leakage and exudation. [@bib4] The submacular location of sclerosing capillary hemangioblastoma has not been reported and to the best of our knowledge, this is the first case report at this abnormal location. We belive that the lesion originated from the underlying choroidal vasculature with subsequent sclerosis.

3. Conclusions {#sec3}
==============

The retinal capillary hemangioblastomas are well-differentiated benign lesions that may affect vision through leakage, exudation and/or hemorrhage.[@bib4] Their presence in the submacular space is unique and has not been reported before.

The absence of these complications in our case may be related to sclerosis, however, it still affects vision due to its location with the disruption of the photoreceptors.

It represents a challenging situation to the surgeon excising this submacular lesion.

The clinical and systemic evaluation must be done to rule out associated von Hippel-Lindau disease.
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